DESIGN, TRANSFORMATION, AND CHARACTERIZATION OF PCDNA3.1(+)-UTR PLASMID IN COVID-19 MRNA VACCINE DEVELOPMENT
Saved in:
Main Author: | Salsabilla Annisa, Kanaya |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/78116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
OPTIMIZATION OF THE PRODUCTION OF PLASMID PCDNA3.1(+) UTR_SPIKE FOR COVID-19 MRNA VACCINE THROUGH VARIATION OF HARVESTING TIME AND CULTIVATION MEDIA
by: Hansyahfanie Badar, Qonita -
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years
by: Wanlapakorn N.
Published: (2023) -
Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination
by: Lim, Xin Rong, et al.
Published: (2023) -
Adverse Cardiac Events Following mRNA COVID-19 Vaccination
by: Eka Arum Cahyaning Putri, Eka, et al. -
SITE-DIRECTED MUTAGENESIS OF SARS-COV-2 ITB SPIKE DNA FOR DEVELOPMENT OF COVID-19 MRNA VACCINE CANDIDATES
by: Lilis Fitriani, Annisa